Biomarker panel (TheraPrint) analyzed as a predictor of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

被引：1
|
作者：
Beitsch, Peter D.
Stork, Lisette
De Snoo, Femke
Peeters, Justine
Whitworth, Pat W.
机构：
[1] Dallas Surg Grp, Dallas, TX USA
[2] Nashville Breast Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
    Brian M Nolen
    Jeffrey R Marks
    Shlomo Ta'san
    Alex Rand
    The Minh Luong
    Yun Wang
    Kimberly Blackwell
    Anna E Lokshin
    [J]. Breast Cancer Research, 10
  • [2] Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
    Nolen, Brian M.
    Marks, Jeffrey R.
    Ta'san, Shlomo
    Rand, Alex
    Luong, The Minh
    Wang, Yun
    Blackwell, Kimberly
    Lokshin, Anna E.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (03):
  • [3] Assessment of biomarker expression in predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Chhieng, David C.
    Rodriguez-Burford, Cristina
    Meleth, Sreelatha
    Grizzle, William E.
    Ferguson, Susan M.
    [J]. BREAST JOURNAL, 2007, 13 (05): : 534 - 535
  • [4] Gene expression panel (TheraPrint) analyzed as predictors of response to neoadjuvant chemotherapy (NCT) in patients (pts) with stage II-III and inflammatory breast cancer (BC).
    Somlo, George
    De Snoo, Femke
    Peeters, Justine
    Stork-Sloots, Lisette
    Simon, Iris
    Robinson, Kim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [5] Gene expression panel (TheraPrint) analyzed as predictors of response to neoadjuvant chemotherapy (NCT) in patients (pts) with stage II-III and inflammatory breast cancer (BC).
    De Snoo, Femke
    Peeters, Justine
    Robinson, Kim
    Stork-Sloots, Lisette
    Simon, Iris
    Somlo, George
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
    Shehata, M.
    Al-Attar, A.
    Reis-Filho, J.
    Ellis, I.
    Mukherjee, A.
    Chan, S.
    [J]. BREAST CANCER RESEARCH, 2010, 12 : S14 - S15
  • [7] Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
    M Shehata
    A Al-Attar
    J Reis-Filho
    I Ellis
    A Mukherjee
    S Chan
    [J]. Breast Cancer Research, 12
  • [8] Response to Neoadjuvant Chemotherapy in Elderly Patients with Locally Advanced Breast Cancer.
    Vanderhaegen, J.
    Wildiers, H.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Neven, P.
    Vergote, I.
    Vanlimbergen, E.
    Weitens, C.
    Janssen, H.
    Moerman, P.
    Brouckaert, O.
    Brouwers, B.
    Paridaens, R.
    [J]. CANCER RESEARCH, 2011, 71
  • [9] Estrogen Receptor Expression: Possible Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
    Wu, J.
    Shen, K.
    Chen, X.
    Chen, C.
    Hu, Z.
    Liu, G.
    Di, G.
    Lu, J.
    Wu, J.
    Shao, Z.
    Shen, Z.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 572S - 572S
  • [10] The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Susnjar, S.
    Stamatovic, L.
    Gavrilovic, D.
    Minic, I.
    Ursulovic, T.
    [J]. BREAST, 2017, 32 : S81 - S82
12345